HLA Restriction of Carbamazepine-Specific T-Cell Clones from an HLA-A*31:01-Positive Hypersensitive Patient
Maike Lichtenfels, John Farrell, Monday O Ogese, Catherine C Bell, Sidonia Eckle, James McCluskey, B Kevin Park, Ana Alfirevic, Dean J Naisbitt, Munir Pirmohamed
Chemical Research in Toxicology | AMER CHEMICAL SOC | Published : 2014
Awarded by European Union
Awarded by Medical Research Council
Awarded by National Institute for Health Research
This work was funded from the European Union's Seventh Framework Programme FP7/2007-2013 under grant agreement number 238132 and the Centre for Drug Safety Science supported by the Medical Research Council (G0700654). M.P. is a NIHR Senior Investigator and is funded by the NHS Chair of Pharmacogenetics from the UK Department of Health.